Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications

J Zielonka, J Joseph, A Sikora, M Hardy… - Chemical …, 2017 - ACS Publications
Mitochondria are recognized as one of the most important targets for new drug design in
cancer, cardiovascular, and neurological diseases. Currently, the most effective way to …

Peptide-mediated delivery of chemical probes and therapeutics to mitochondria

SR Jean, M Ahmed, EK Lei… - Accounts of chemical …, 2016 - ACS Publications
Conspectus Mitochondria are organelles with critical roles in key processes within
eukaryotic cells, and their dysfunction is linked with numerous diseases including …

Metabolic tricks of cancer cells

K Hönigova, J Navratil, B Peltanova… - … et Biophysica Acta (BBA …, 2022 - Elsevier
One of the characteristics of cancer cells important for tumorigenesis is their metabolic
plasticity. Indeed, in various stress conditions, cancer cells can reshape their metabolic …

Mitochondrial biology, targets, and drug delivery

L Milane, M Trivedi, A Singh, M Talekar… - Journal of Controlled …, 2015 - Elsevier
In recent years, mitochondrial medicine has emerged as a new discipline resting at the
intersection of mitochondrial biology, pathology, and pharmaceutics. The central role of …

Reconsidering azobenzene as a component of small-molecule hypoxia-mediated cancer drugs: A theranostic case study

P Verwilst, J Han, J Lee, S Mun, HG Kang, JS Kim - Biomaterials, 2017 - Elsevier
An azobenzene scaffold serves as both a fluorescence quencher and nitrogen mustard
deactivator in a mitochondrial targeting unit bearing theranostic drug delivery system (DDS) …

Trackable mitochondria-targeting nanomicellar loaded with doxorubicin for overcoming drug resistance

Y Zhang, C Zhang, J Chen, L Liu, M Hu… - ACS applied materials …, 2017 - ACS Publications
Multidrug resistance (MDR) has been recognized as a major obstacle to successful
chemotherapy for cancer in the clinic. In recent years, more and more nanoscaled drug …

Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer

L Shen, X Zhan - Oxidative Medicine and Cellular Longevity, 2022 - Wiley Online Library
The mitochondrion is a very versatile organelle that participates in some important cancer‐
associated biological processes, including energy metabolism, oxidative stress …

[HTML][HTML] 9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer …

N Ali, C Wolf, S Kanchan, SR Veerabhadraiah… - Biomedicine & …, 2024 - Elsevier
Nullomers are the shortest strings of absent amino acid (aa) sequences in a species or
group of species. Primes are those nullomers that have not been detected in the genome of …

Mitochondrion-targeting peptides and peptidomimetics: recent progress and design principles

S Kim, HY Nam, J Lee, J Seo - Biochemistry, 2019 - ACS Publications
Mitochondria are multifunctional subcellular organelles whose operations encompass
energy production, signal transduction, and metabolic regulation. Given their wide range of …

Mitochondrial targeting of doxorubicin eliminates nuclear effects associated with cardiotoxicity

SR Jean, DV Tulumello, C Riganti… - ACS chemical …, 2015 - ACS Publications
The highly effective anticancer agent doxorubicin (Dox) is a frontline drug used to treat a
number of cancers. While Dox has a high level of activity against cancer cells, its clinical use …